MeSH tree: A11.118.637.555.567.550
Some people carry antibodies that block the body's early defenses against viruses, increasing their risk of developing severe illnesses such as severe COVID-19. Researchers at Karolinska Institutet have now identified the ...
5 hours ago
0
0
Trillions of bacteria live in the human gut without triggering an immune response. Scientists at St. Jude Children's Research Hospital have now discovered a gene-regulatory pathway that helps maintain this delicate balance. ...
Oct 29, 2026
0
25
Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat prostate cancers temporarily activate the body's immune response before those immune effects begin ...
Oct 29, 2026
0
10
Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of immunotherapy patients to experience serious side effects and showed that diet and microbiome composition influence ...
Oct 22, 2026
0
675
Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally. Published in Cancer Cell, the WEHI study found patients ...
Oct 15, 2026
0
16
In the past, immune cells were all simply known as white blood cells. Nowadays, we know that there are T cells, B lymphocytes, macrophages, autoreactive T helper cells, microglia, Tregs and others. Together, they form a team ...
Oct 14, 2026
0
6
Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion ...
Oct 9, 2026
0
17
A 'rising fog' may cloud the immune system's ability to detect tumors and may be the key to tackling lung cancer that is developing years before diagnosis. The team at University College London (UCL) followed this signal ...
Oct 8, 2026
0
16
Researchers at the Francis Crick Institute, King's College London and Complutense University of Madrid have shown that γδ T cells use adaptive immune receptors to drive rapid, innate-like responses to tissue stress, inflammation ...
Sep 30, 2026
0
30
Patients with metastatic squamous non-small cell lung cancer (NSCLC) whose disease progressed following PD-(L)1 inhibitor therapy experienced a median overall survival of 18.5 months with the investigational anti-CTLA-4 antibody ...
Sep 15, 2026
0
6
